307 related articles for article (PubMed ID: 18222493)
1. Chronic haloperidol and clozapine produce different patterns of effects on phosphodiesterase-1B, -4B, and -10A expression in rat striatum.
Dlaboga D; Hajjhussein H; O'Donnell JM
Neuropharmacology; 2008 Mar; 54(4):745-54. PubMed ID: 18222493
[TBL] [Abstract][Full Text] [Related]
2. Levels of phosphodiesterase 4A and 4B are altered by chronic treatment with psychotropic medications in rat frontal cortex.
Fatemi SH; Folsom TD; Reutiman TJ; Braun NN; Lavergne LG
Synapse; 2010 Jul; 64(7):550-5. PubMed ID: 20222156
[TBL] [Abstract][Full Text] [Related]
3. Decreased adenosine cyclic 3',5'-monophosphate phosphodiesterase activity in rat straitum following chronic haloperidol treatment.
Fredholm BB
Med Biol; 1977 Feb; 55(1):61-5. PubMed ID: 191703
[TBL] [Abstract][Full Text] [Related]
4. Effects of chronic haloperidol and clozapine treatment on neurotensin and c-fos mRNA in rat neostriatal subregions.
Merchant KM; Dobie DJ; Filloux FM; Totzke M; Aravagiri M; Dorsa DM
J Pharmacol Exp Ther; 1994 Oct; 271(1):460-71. PubMed ID: 7965747
[TBL] [Abstract][Full Text] [Related]
5. cDNA array reveals increased expression of glucose-dependent insulinotropic polypeptide following chronic clozapine treatment: role in atypical antipsychotic drug-induced adverse metabolic effects.
Sondhi S; Castellano JM; Chong VZ; Rogoza RM; Skoblenick KJ; Dyck BA; Gabriele J; Thomas N; Ki K; Pristupa ZB; Singh AN; MacCrimmon D; Voruganti P; Foster J; Mishra RK
Pharmacogenomics J; 2006; 6(2):131-40. PubMed ID: 16402076
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the striatum-enriched phosphodiesterase PDE10A: a novel approach to the treatment of psychosis.
Siuciak JA; Chapin DS; Harms JF; Lebel LA; McCarthy SA; Chambers L; Shrikhande A; Wong S; Menniti FS; Schmidt CJ
Neuropharmacology; 2006 Aug; 51(2):386-96. PubMed ID: 16780899
[TBL] [Abstract][Full Text] [Related]
7. Differential expression and regulation of the cAMP-selective phosphodiesterase type 4A splice variants in rat brain by chronic antidepressant administration.
D'Sa C; Eisch AJ; Bolger GB; Duman RS
Eur J Neurosci; 2005 Sep; 22(6):1463-75. PubMed ID: 16190900
[TBL] [Abstract][Full Text] [Related]
8. Select 3',5'-cyclic nucleotide phosphodiesterases exhibit altered expression in the aged rodent brain.
Kelly MP; Adamowicz W; Bove S; Hartman AJ; Mariga A; Pathak G; Reinhart V; Romegialli A; Kleiman RJ
Cell Signal; 2014 Feb; 26(2):383-97. PubMed ID: 24184653
[TBL] [Abstract][Full Text] [Related]
9. Striatal phosphodiesterase mRNA and protein levels are reduced in Huntington's disease transgenic mice prior to the onset of motor symptoms.
Hebb AL; Robertson HA; Denovan-Wright EM
Neuroscience; 2004; 123(4):967-81. PubMed ID: 14751289
[TBL] [Abstract][Full Text] [Related]
10. PDE9A, PDE10A, and PDE11A expression in rat trigeminovascular pain signalling system.
Kruse LS; Møller M; Tibaek M; Gammeltoft S; Olesen J; Kruuse C
Brain Res; 2009 Jul; 1281():25-34. PubMed ID: 19445908
[TBL] [Abstract][Full Text] [Related]
11. Altered expression of PDE1 and PDE4 cyclic nucleotide phosphodiesterase isoforms in 7-oxo-prostacyclin-preconditioned rat heart.
Kostic MM; Erdogan S; Rena G; Borchert G; Hoch B; Bartel S; Scotland G; Huston E; Houslay MD; Krause EG
J Mol Cell Cardiol; 1997 Nov; 29(11):3135-46. PubMed ID: 9405187
[TBL] [Abstract][Full Text] [Related]
12. The induction of cyclic nucleotide phosphodiesterase 4 gene (PDE4D) impairs memory in a water maze task.
Giorgi M; Modica A; Pompili A; Pacitti C; Gasbarri A
Behav Brain Res; 2004 Sep; 154(1):99-106. PubMed ID: 15302115
[TBL] [Abstract][Full Text] [Related]
13. Chronic suppression of phosphodiesterase 10A alters striatal expression of genes responsible for neurotransmitter synthesis, neurotransmission, and signaling pathways implicated in Huntington's disease.
Kleiman RJ; Kimmel LH; Bove SE; Lanz TA; Harms JF; Romegialli A; Miller KS; Willis A; des Etages S; Kuhn M; Schmidt CJ
J Pharmacol Exp Ther; 2011 Jan; 336(1):64-76. PubMed ID: 20923867
[TBL] [Abstract][Full Text] [Related]
14. Characterization of 3',5' cyclic nucleotide phosphodiesterase activity in Y79 retinoblastoma cells: absence of functional PDE6.
White JB; Thompson WJ; Pittler SJ
Mol Vis; 2004 Oct; 10():738-49. PubMed ID: 15480303
[TBL] [Abstract][Full Text] [Related]
15. Differential changes in the expression of cyclic nucleotide phosphodiesterase isoforms in rat brains by chronic treatment with electroconvulsive shock.
Cho CH; Cho DH; Seo MR; Juhnn YS
Exp Mol Med; 2000 Sep; 32(3):110-4. PubMed ID: 11048640
[TBL] [Abstract][Full Text] [Related]
16. Typical and atypical antipsychotic drugs target dopamine and cyclic AMP-regulated phosphoprotein, 32 kDa and neurotensin-containing neurons, but not GABAergic interneurons in the shell of nucleus accumbens of ventral striatum.
Ma J; Ye N; Cohen BM
Neuroscience; 2006 Sep; 141(3):1469-80. PubMed ID: 16781818
[TBL] [Abstract][Full Text] [Related]
17. Differential sensitivity of two dopaminergic structures in rat brain to haloperidol and to clozapine.
Wilk S; Watson E; Stanley ME
J Pharmacol Exp Ther; 1975 Nov; 195(2):265-70. PubMed ID: 1185596
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of IEG mRNA in rat brain following acute treatment with clozapine or haloperidol: a semi-quantitative RT-PCR study.
Robbins MJ; Critchlow HM; Lloyd A; Cilia J; Clarke JD; Bond B; Jones DN; Maycox PR
J Psychopharmacol; 2008 Jul; 22(5):536-42. PubMed ID: 18208916
[TBL] [Abstract][Full Text] [Related]
19. Effect of drugs stimulating dopaminergic system on phosphodiesterase activity in rat striatum.
Janiec W; Piekarska T; Szczypior M; Misterkiewicz E
Pol J Pharmacol Pharm; 1976; 28(6):631-4. PubMed ID: 189292
[TBL] [Abstract][Full Text] [Related]
20. Striatal and nigral COX-2 expression after chronic typical and atypical neuroleptic administration in rats.
Marin C; Saldaña M; Roca-Ferrer J; Bonastre M; Aguilar E; Mullol J
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):678-82. PubMed ID: 17289239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
